Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Arthritis Research & Therapy|September 20, 2017
Inflammasome lights up in systemic sclerosisJohn Henderson, Steven O'ReillyJournal of Autoimmunity|July 28, 2020
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosisJulie C Worrell, Steven O'ReillyTrends in Molecular Medicine|March 13, 2019
The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable TargetJohn Henderson, Joerg Distler, Steven O'ReillyCells|July 26, 2024
The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic SclerosisPaul Freedman, Bettina Schock, Steven O'ReillyExperimental Dermatology|February 26, 2015
Current frontiers in systemic sclerosis pathogenesisMarzena Ciechomska, Jacob van Laar, Steven O'ReillyTrends in Molecular Medicine|June 18, 2024
Senescence and tissue fibrosis: opportunities for therapeutic targetingSteven O'Reilly, Pei-Suen Tsou, John VargaNature Reviews. Rheumatology|September 4, 2021
Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potentialPei-Suen Tsou, John Varga, Steven O'ReillyFrontiers in Immunology|November 1, 2024
Aging, senescence, and cutaneous wound healing-a complex relationshipSteven O'Reilly, Ewa Markiewicz, Olusola C IdowuCurrent Rheumatology Reports|January 25, 2017
Innate Immunity in Systemic SclerosisChristopher Dowson, Nathan Simpson, Laura Duffy, et al.Experimental Dermatology|June 28, 2020
Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3pJohn Henderson, Stefan Pryzborski, Richard Stratton, et al.Pageof 8